In 1971 Vane and coworkers made the landmark observation
that aspirin and some NSAIDs
blocked PG generation. This is now considered to be the
major mechanism of action of NSAIDs.
Prostaglandins, prostacyclin (PG I2) and Thromboxane A2 (TXA2) are produced from
arachidonic acid by the enzyme cyclooxygenase which exists in a
- constitutive (COX-1 ) and
- an inducible (COX-2) isoforms;
the latter [inducible (COX-2)] ànormally
present in minute quantities,
is induced by cytokines and other signal molecules at the
site of inflammation à
generation of
PGs locally which mediate many of the inflammatory changes.
However, COX-2 is constitutively
present at some sites in brain and in juxtaglomerular cells:
may serve physiological role at
these sites.
Most NSAIDs inhibit COX-1 and COX-2 nonselectively,
but now some selective COX-2 inhibitors have been produced.
Most NSAIDs inhibit COX-1 and COX-2 nonselectively,
but now some selective COX-2 inhibitors have been produced.
Aspirin inhibits COX irreversibly by acetylating one of its
serine residues; return of COX
activity depends on synthesis of fresh enzyme.
Beneficial action due to PG synthesis Inhibition::-
Beneficial action due to PG synthesis Inhibition::-
• Analgesia: prevention of pain nerve ending sensitization
• Antipyresis
• Antiinflammatory
• Antithrombotic
• Closure of ductus arteriosus in newborn ' " ...
Other NSAIDs are competitive and reversible
inhibitors of COX, return of activity depends on
their dissociation from the enzyme which in turn
is governed by the pharmacokinetic characteristics of the
compound.